Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-729418
Filing Date
2016-10-03
Accepted
2016-10-03 17:00:56
Documents
6
Period of Report
2016-11-11
Effectiveness Date
2016-10-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d204400ddef14a.htm DEF 14A 180137
2 GRAPHIC g204400g11y77.jpg GRAPHIC 26592
3 GRAPHIC g204400g18u22.jpg GRAPHIC 43967
4 GRAPHIC g204400g21j11.jpg GRAPHIC 24658
5 GRAPHIC g204400g56z83.jpg GRAPHIC 16586
6 GRAPHIC g204400g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-16-729418.txt   366932
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21990 | Film No.: 161916342
SIC: 2836 Biological Products, (No Diagnostic Substances)